Each January, San Francisco becomes the epicenter of the global biopharmaceutical industry as executives, innovators, and investors gather for JPM Week. Anchored by the 44th Annual J.P. Morgan Healthcare Conference, the week is filled with high-impact partnering meetings, scientific discussions, and networking events that shape the year ahead for healthcare and life sciences.
Olon USA will be in San Francisco during JPM Week, actively engaging in key ancillary events and meetings across the city. Our team looks forward to connecting with biopharma leaders to exchange insights, explore collaborations, and discuss how we can support innovative small molecule programs from development through commercialization.
Meaningful Conversations Beyond the Main Stage
While the J.P. Morgan Healthcare Conference sets the tone for the week, many of the most productive conversations happen throughout the surrounding ecosystem of showcases, receptions, and partnering events. JPM Week provides a unique opportunity to meet decision-makers and innovators in a more focused, relationship-driven environment.
Olon USA values these moments for open dialogue around emerging pipelines, development challenges, and long-term manufacturing strategies. Being present during JPM Week allows us to stay closely aligned with the evolving needs of biotech and pharmaceutical companies across the industry.
Participating in Key JPM Week Events
During the week, Olon USA Business Development Director Johnny Chapman and Business Development Manager Bea Ongwong will be attending several notable JPM Week events designed to foster collaboration and dealmaking. On January 12, the team plans to take part in Biotech Dealmaking, followed by Translating Discovery into Targeted Therapies, an event focused on bridging early research with clinical impact. That same evening, they will attend the Midwest Biotech Startup Showcase, highlighting emerging companies and innovative platforms shaping the next generation of therapeutics, as well as the DLA Piper Late Night Reception.
On January 13, the Olon USA team will continue conversations at the Endpoint at JPM26 Networking Reception before joining Polsinelli’s 2026 J.P. Morgan Reception at Chotto Matte and the DLA Piper Reception later in the evening. The week concludes on January 14 with participation in the Life Science and Digital Health Startup Founder Mixer hosted by Endless Frontier Labs, bringing together founders, investors, and strategic partners across life sciences and digital health.
These events reflect Olon USA’s commitment to engaging across the full spectrum of the biopharma ecosystem, from early-stage startups to established organizations seeking trusted CDMO support.
A U.S.-Based CDMO Partner Focused on Long-Term Success
Olon USA offers deep expertise in small molecule development and manufacturing, supported by a strong U.S. footprint and a collaborative, quality-driven approach. Our integrated services enable us to support customers from early development through commercial supply, helping reduce risk, improve efficiency, and accelerate timelines.
JPM Week provides an ideal environment to discuss how Olon USA can support innovative pipelines with flexible, scalable, and compliant solutions tailored to each program’s unique needs.
Let’s Connect During JPM Week
If you’ll be in San Francisco during JPM Week and are looking to connect with a trusted CDMO partner, we encourage you to reach out to Olon USA. Our team would welcome the opportunity to schedule a meeting, learn more about your development goals, and explore how we can support your next milestone.
Connect with Olon USA to make the most of JPM Week and start a conversation that could move your program forward with confidence. We look forward to connecting with you in San Francisco.